BY4 (Primaquine phosphate 15mg (base))
Pill imprint BY4 has been identified as Primaquine phosphate 15mg (base).
Primaquine is used in the treatment of pneumocystis pneumonia; malaria prevention; malaria and belongs to the drug class antimalarial quinolines. FDA has not classified the drug for risk during pregnancy. Primaquine 15mg (base) is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- BY4
- Strength:
- 15mg (base)
- Color:
- Purple
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antimalarial quinolines
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Bayshore Pharmaceuticals, LLC
More about primaquine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: antimalarial quinolines
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
